Jubilant Pharmova Limited has informed the Exchange regarding Appointment of Mr. Arjun Shanker Bhartia as Joint Managing Director of the company w.e.f. Jun 01, 2026.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova's Board has approved the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director for another three years starting June 1, 2026. Both appointments are subject to shareholder approval. Priyavrat Bhartia (49 years), son of Chairman Shyam Sunder Bhartia, has been with the company since 2017 and was last re-appointed as Managing Director in June 2023. Arjun Shanker Bhartia (39 years), son of Co-Chairman Hari Shanker Bhartia, also joined the board in 2017 and has been Joint Managing Director since June 2023. Both are from the promoter family.
This is a routine leadership continuity announcement with no change in strategy or new faces. Both Bhartia family members continue in executive roles, ensuring promoter control remains intact. Shareholders will vote on these re-appointments at the upcoming general meeting.